chriswilson2020
Chris Wilson
Board Member at Sensible Healthcare Systems
Nijmegen, The Netherlands

I am not only a natural disruptor to innovation. I possess a skill that enables me to translate the science of Chemistry, Medical Devices and Biotech, into the business numbers. I am a commercially oriented leader with a proven scientific background. I have a PhD in Advanced Materials and a specialization in Health Economics and Policy, which enable me to combine technical knowledge with business acumen and regulatory insight. As a confident leader, I can oversee operations management, strategic new business development, clinical trials, and research and development. I have had particular experiences and successes in development and clinical validation of disruptive medical sensors, tissue regenerative scaffolds and implants, and cold chain delivery of biologics Currently, I am the Director of Operations and interim QA/RA Director at AQPHA Medical BV, where I am responsible for strategic partnerships creating commercial value, transition to MDR and ensuring the compliance and running of ISO 13485 Quality System, ISO 14971 compliant Risk Management. I led the clinical program and liaised with principal investigators and other stakeholders for Parkinson Smartwatch, a digital therapeutic for movement disorders. In my consulting practice Listerdale Life Sciences BV, I raised over 36M Euro in equity and non-dilutive funding for early-stage companies in the medical space and provided management consulting and audit services. My passion is to build companies that improve the quality of life for patients and society. I am looking to move into a permanent role, to utilise the extensive skills I have accumulated in running my consulting contracting business. Available for Contract | Temp | Perm Working in locations in a hybrid capacity NL, BE, UK, FR, DE Working remote in US, UK & EMEA Can operate as: Scientist | Director Life Science Business | Operations Director | COO | Clinical Director | Director QA/RA | Vice President Research and Development R&D | Business Development | Board Advisor Let's discuss opportunities

CodersRank Score

What is this?

This represents your current experience. It calculates by analyzing your connected repositories. By measuring your skills by your code, we are creating the ranking, so you can know how good are you comparing to another developers and what you have to improve to be better

Information on how to increase score and ranking details you can find in this blog post.

263.1
CodersRank Rank
Top 3%
Top 1
C
C
Developer
The Netherlands
Top 1
Jupyter Notebook
Jupyter Notebook
Developer
The Netherlands
Top 5
Python
Python
Developer
The Netherlands
Highest experience points: 0 points,

0 activities in the last year

List your work history, including any contracts or internships
Sensible Healthcare Systems
Sep 2022 - Present (2 years 7 months)
Delft, South Holland Current workspace
Currently Chris Wilson supports the Sensible Healthcare Systems

Chris Wilson's scores will be added to this company.

Board Member
Serving on the board of a company developing a minimally invasive continuous glucose sensor platform.

Fundraising Success: Supported the company to secure pre-seed financing, providing essential early-stage funding for the company.

Strategic Partnerships: Facilitated discussions with strategic partners, leading to negotiations for two new partnership agreements.

Executive Support: Provided strategic guidance and support to the CEO and management team, aiding in the development and achievement of key strategic objectives.
Parkinson Smartwatch
Oct 2021 - Feb 2023 (1 year 4 months)
Arnhem. Netherlands
Clinical Director
Advisor to the board on clinical strategy. Design of clinical programs clinical trial development and reviewing clinical trial reports. Ensure compliance to GCP and ISO 14155. Liaising with principal investigators and other stakeholders. Developed and lead the clinical program as well including post market surveillance activities in line with MDD and prepared the clinical program for MDR compliance. Reviewed and wrote clinical protocols and worked with principal investigators and CRA's to develop clinical trials to demonstrate the effectiveness of this digital therapeutic in the domain of movement disorders.

From Oct 2021 to March 2022 filled the role of senior business developer aligning the clinical program to business goals and developing strategic alliances in beach head markets.
AQPHA Medical BV
Jan 2021 - Present (4 years 3 months)
Utrecht, Netherlands Current workspace
Currently Chris Wilson supports the AQPHA Medical BV

Chris Wilson's scores will be added to this company.

Director of Business Development and Operations
Full operational accountability for this CDMO, ensuring excellence in innovation, regulatory compliance and operational efficiency.

Financial Oversight: P&L responsibility for a €2.5M annual budget, optimizing resource allocation and financial performance.

Regulatory Excellence: Achieved 100% regulatory and quality compliance and ISO 13485 certification by implementing robust processes and comprehensive training programs.

Strategic Transition: Transitioned the company from preclinical stages into clinical trials, marking a significant milestone in product development.

Product Innovation: Led the development and launch of the first terminally sterilized injectable dermal filler product, securing a five-year supply agreement.

Commercial Success: Launched the first commercial product, achieving initial revenues of (Dec 2023), with confirmed orders for proceeding 5 years.

Site wide operational management including: P&L, finance, budgeting, supply chain, product development, manufacturing, regulatory, quality assurance for class three medical devices and CDMO activities.

Responsible for compliance and running of ISO 13485 Quality System, ISO 14971 compliant Risk Management, MDR compliance.

Lead strategic new business development building own products and CDMO activities.

This section lets you add any degrees or diplomas you have earned.
The London School of Economics and Political Science (LSE)
Health Economics and Policy
Mar 2022 - Jul 2022
University of Hull
PhD, Advanced Organic Materials
Jan 2004 - Jan 2007
University of Hull
Doctor of Philosophy - PhD, Advanced Materials
Jan 2004 - Jan 2007
University of Hull
MChem, Chemistry Drug Design and Toxicollogy
Jan 2000 - Jan 2004
ISO 19011:2018 Management System Auditor Training
Jul 2023
Internal audit on Medical Device QMS - ISO 13485:2016
Jul 2023
Health Economics and Policy
Jun 2022

Jobs for you

Show all jobs
Feedback